Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Last Call for Cyber Monday! Save Now on Claim 60% OFF
Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case
Published Feb 06, 2020 06:29PM ET
© Reuters. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York
By Lisa Girion and Michael Erman
(Reuters) - Johnson & Johnson (NYSE:JNJ) was ordered on Thursday by a New Jersey state jury to pay punitive damages of $750 million to four plaintiffs who allege that the company's Baby Powder caused their cancer, a ruling that will be reduced to around $185 million because of state laws, according to a lawyer for the plaintiffs and the company.
During an earlier phase of the trial, a different jury held J&J liable for the plaintiffs' cancers and awarded them $37.2 million in compensation.
Under New Jersey law, punitive damages are capped at 5 times the amount of compensatory damages, according to plaintiffs lawyer Chris Placitella.
J&J said in a statement it would quickly appeal both phases of the trial, citing "numerous legal errors that subjected the jury to irrelevant information and prevented them from hearing meaningful evidence."
The verdict came after J&J Chief Executive Alex Gorsky testified last month for the first time in a jury trial over allegations that the company's Baby Powder causes cancer.
"We believe the jury was speaking directly to Alex Gorsky," plaintiffs lawyer Placitella said.
J&J faces more than 16,000 lawsuits alleging it sold powders contaminated with asbestos and failed to warn users. It also faces a federal criminal investigation into how forthright it has been about the products' safety.
J&J denies that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown its talc to be safe and asbestos-free.
On Dec. 14, 2018, Reuters published a story that showed J&J had failed to disclose that small amounts of asbestos, a known carcinogen, had sometimes been found in its talc over several decades. After the report was published, a selloff wiped more than $40 billion off the company's market value.
At the time, J&J dismissed the Reuters' report as "an absurd conspiracy theory."
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.